Evaluation of long term cardiotoxicity after epirubicin containing adjuvant chemotherapy and locoregional radiotherapy for breast cancer using various detection techniques

Heart. 2002 Jul;88(1):81-2. doi: 10.1136/heart.88.1.81.
No abstract available

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibiotics, Antineoplastic / administration & dosage
  • Antibiotics, Antineoplastic / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / radiotherapy
  • Chemotherapy, Adjuvant
  • Chronic Disease
  • Cross-Sectional Studies
  • Cyclophosphamide / administration & dosage
  • Dyspnea / chemically induced
  • Epirubicin / administration & dosage
  • Epirubicin / adverse effects*
  • Female
  • Fluorouracil / administration & dosage
  • Heart Diseases / chemically induced*
  • Humans
  • Long-Term Care
  • Middle Aged

Substances

  • Antibiotics, Antineoplastic
  • Epirubicin
  • Cyclophosphamide
  • Fluorouracil

Supplementary concepts

  • FEC protocol